Global Paclitaxel Injection Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028176 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Paclitaxel Injection market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Paclitaxel Injection market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Paclitaxel Injection in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg
Market Snapshot, By Application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other
Main Market Players Analyzed in this report, including:
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Yizhong Pharm
Osmia
Sun Pharma
Fresenius Kabi
Samyang
The study objectives of this report are:
To study and analyze the global Paclitaxel Injection market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Paclitaxel Injection market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Paclitaxel Injection manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paclitaxel Injection market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Paclitaxel Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Paclitaxel Injection are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Paclitaxel Injection Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Paclitaxel Injection Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Paclitaxel Injection
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Paclitaxel Injection Sales Channel and Distributors Analysis
3.3.1 Paclitaxel Injection Sales Channel
3.3.2 Paclitaxel Injection Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Ovarian Cancer
3.4.2 Major Buyers in Breast Cancer
3.5 Paclitaxel Injection Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Paclitaxel Injection Type Introduction
4.1.1 5ml,30mg
4.1.2 10ml,60mg
4.1.3 16.7ml,100mg
4.1.4 25ml,150mg
4.1.5 50ml,300mg
4.2 Global Paclitaxel Injection Sales by Type 2016-2021
4.3 Global Paclitaxel Injection Revenue by Type 2016-2021
4.4 Global Paclitaxel Injection Price by Type 2016-2021
5 Market Segment: by Application
5.1 Paclitaxel Injection Type Introduction
5.1.1 Ovarian Cancer
5.1.2 Breast Cancer
5.1.3 Cervical Cancer
5.1.3 Pancreatic Cancer
5.1.4 Other
5.2 Global Paclitaxel Injection Sales by Application 2016-2021
5.3 Global Paclitaxel Injection Revenue by Application 2016-2021
5.4 Global Paclitaxel Injection Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Paclitaxel Injection Market by Region
6.1.1 Global Paclitaxel Injection Sales by Regions
6.1.2 Global Paclitaxel Injection Revenue by Regions
6.2 North America Paclitaxel Injection Market 2016-2021
6.3 Europe Paclitaxel Injection Market 2016-2021
6.4 Asia Pacific Paclitaxel Injection Market 2016-2021
6.5 South America Paclitaxel Injection Market 2016-2021
6.6 Middle East and Africa Paclitaxel Injection Market 2016-2021
7 North America
7.1 North America Paclitaxel Injection Market by Country 2016-2021
7.1.1 North America Paclitaxel Injection Sales by Country
7.1.2 North America Paclitaxel Injection Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Paclitaxel Injection Market by Country 2016-2021
8.1.1 Europe Paclitaxel Injection Sales by Country
8.1.2 Europe Paclitaxel Injection Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Paclitaxel Injection Market by Country 2016-2021
9.1.1 Asia Pacific Paclitaxel Injection Sales by Country
9.1.2 Asia Pacific Paclitaxel Injection Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Paclitaxel Injection Market by Country 2016-2021
10.1.1 South America Paclitaxel Injection Sales by Country
10.1.2 South America Paclitaxel Injection Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Paclitaxel Injection Market by Country 2016-2021
11.1.1 Middle East and Africa Paclitaxel Injection Sales by Country
11.1.2 Middle East and Africa Paclitaxel Injection Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Information
12.1.2 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio, Specification and Application
12.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Bristol-Myers Squibb Key Development
12.2 Celgene Corporation
12.2.1 Celgene Corporation Company Information
12.2.2 Celgene Corporation Paclitaxel Injection Product Portfolio, Specification and Application
12.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Celgene Corporation Key Development
12.3 Hospira
12.3.1 Hospira Company Information
12.3.2 Hospira Paclitaxel Injection Product Portfolio, Specification and Application
12.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Hospira Key Development
12.4 Biological E.
12.4.1 Biological E. Company Information
12.4.2 Biological E. Paclitaxel Injection Product Portfolio, Specification and Application
12.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Biological E. Key Development
12.5 Taj Accura
12.5.1 Taj Accura Company Information
12.5.2 Taj Accura Paclitaxel Injection Product Portfolio, Specification and Application
12.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Taj Accura Key Development
12.6 Khandelwal Laboratories
12.6.1 Khandelwal Laboratories Company Information
12.6.2 Khandelwal Laboratories Paclitaxel Injection Product Portfolio, Specification and Application
12.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Khandelwal Laboratories Key Development
12.7 Luye Pharma
12.7.1 Luye Pharma Company Information
12.7.2 Luye Pharma Paclitaxel Injection Product Portfolio, Specification and Application
12.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Khandelwal Laboratories Key Development
12.9 Osmia
12.9.1 Osmia Company Information
12.9.2 Osmia Paclitaxel Injection Product Portfolio, Specification and Application
12.9.3 Osmia Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Osmia Key Development
12.8 Yizhong Pharm
12.8.1 Yizhong Pharm Company Information
12.8.2 Yizhong Pharm Paclitaxel Injection Product Portfolio, Specification and Application
12.8.3 Yizhong Pharm Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Yizhong Pharm Key Development
12.11 Fresenius Kabi
12.11.1 Fresenius Kabi Company Information
12.11.2 Fresenius Kabi Paclitaxel Injection Product Portfolio, Specification and Application
12.11.3 Fresenius Kabi Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Fresenius Kabi Key Development
12.12 Samyang
12.12.1 Samyang Company Information
12.12.2 Samyang Paclitaxel Injection Product Portfolio, Specification and Application
12.12.3 Samyang Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Samyang Key Development
13 Global Paclitaxel Injection Market Forecast by Region by Type and by Application
13.1 Global Paclitaxel Injection Sales, Revenue Forecast 2022-2027
13.2 Global Paclitaxel Injection Forecast by Regions
13.2.1 Global Paclitaxel Injection Sales Forecast by Region 2022-2027
13.2.2 Global Paclitaxel Injection Revenue Forecast by Region 2022-2027
13.3 Global Paclitaxel Injection Forecast by Type
13.3.1 Global Paclitaxel Injection Sales Forecast by Type 2022-2027
13.3.2 Global Paclitaxel Injection Revenue Forecast by Type 2022-2027
13.3.3 Global Paclitaxel Injection Price Forecast by Type 2022-2027
13.4 Global Paclitaxel Injection Forecast by Application
13.4.1 Global Paclitaxel Injection Sales Forecast by Application 2022-2027
13.4.2 Global Paclitaxel Injection Revenue Forecast by Application 2022-2027
13.4.3 Global Paclitaxel Injection Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com